Fjölsetra, slembiröðuð, tvíblind, rannsókn þar sem verkun og öryggi meðferðar með QAW039 er borið saman við lyfleysu í 52 vikur, sem viðbót við astmameðferð sem fyrir er, hjá sjúklingum með ómeðhöndlaðan, slæman astma
A 52-week, multicenter, randomized, double-blind, placebo controlled study to assess the efficacy and safety of QAW039 when added to existing asthma therapy in patients with uncontrolled severe asthma.
Development of evidence-based follow-up strategy after treatment for renal cell cancer: Retrospective and prospective analysis of multicentre Europena databases
Use of 256-EEG facility with filtered EMG artifact to assess Cortical Neurodynamics and Spatiotemporal Mapping of Language and Memory Pathways in the Human Brain